Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 28, 2023 Filed Nov 29, 2023 23:31 UTC |
KAY CHRISTINADirector · Co-Chief Executive Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $0.26 | $0.00 |
DisclosureSEC source: 0001345281-23-000008 · primary_doc.xml · derivative · entry 1 KAY CHRISTINA · CIK 0001064901 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2033-11-28 F1 · derivative.exercise_date: The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 28, 2024. Read SEC document |
| November 28, 2023 Filed Nov 29, 2023 22:14 UTC |
Masi DinaChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001345281-23-000007 · primary_doc.xml · derivative · entry 1 Masi Dina · CIK 0001345281 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2033-11-28 F1 · derivative.exercise_date: The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 28, 2024. Read SEC document |
| September 20, 2023 Filed Sep 21, 2023 20:17 UTC |
RIVA SHEPPARDDirector · Co-Chief Executive Officer · 10% owner
|
Disposition to issuerStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.09 | $0.00 |
DisclosureSEC source: 0001064900-23-000002 · primary_doc.xml · derivative · entry 6 RIVA SHEPPARD · CIK 0001064900 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 50,000 shares Expires 2025-06-02 Read SEC document |
| September 20, 2023 Filed Sep 21, 2023 20:17 UTC |
RIVA SHEPPARDDirector · Co-Chief Executive Officer · 10% owner
|
GrantCommon Stock | 50,000 | $0.09 | $4,500.00 |
DisclosureSEC source: 0001064900-23-000002 · primary_doc.xml · nonDerivative · entry 2 RIVA SHEPPARD · CIK 0001064900 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,273,467 F4 · date: 50,000 common stock shares acquired upon exercise of stock option grant dated June 2, 2015. Read SEC document |
| September 20, 2023 Filed Sep 21, 2023 19:41 UTC |
KAY CHRISTINADirector · Co-Chief Executive Officer · 10% owner
|
Disposition to issuerStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.09 | $0.00 |
DisclosureSEC source: 0001064901-23-000002 · primary_doc.xml · derivative · entry 6 KAY CHRISTINA · CIK 0001064901 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 50,000 shares Expires 2025-06-02 Read SEC document |
| September 20, 2023 Filed Sep 21, 2023 19:41 UTC |
KAY CHRISTINADirector · Co-Chief Executive Officer · 10% owner
|
GrantCommon Stock | 50,000 | $0.09 | $4,500.00 |
DisclosureSEC source: 0001064901-23-000002 · primary_doc.xml · nonDerivative · entry 2 KAY CHRISTINA · CIK 0001064901 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,273,467 F3 · kind: 50,000 common stock shares acquired upon exercise of stock option grant dated June 2, 2015. Read SEC document |
| September 20, 2023 Filed Sep 21, 2023 14:51 UTC |
Masi DinaChief Financial Officer
|
Disposition to issuerStock Option (right to buy) · Derivative | 50,000 | $0.09 Strike: $0.09 | $4,500.00 |
DisclosureSEC source: 0001345281-23-000004 · primary_doc.xml · derivative · entry 2 Masi Dina · CIK 0001345281 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 576,667 Underlying: Common Stock · 50,000 shares Expires 2025-06-02 F2 · kind: 50,000 stock options disposed of upon exercise of the portion of a stock option grant dated June 2, 2015. 200,000 stock options for the right to purchase common stock at $0.09 remain available to exercise. Read SEC document |
| September 20, 2023 Filed Sep 21, 2023 14:51 UTC |
Masi DinaChief Financial Officer
|
GrantCommon Stock | 50,000 | $0.09 | $4,500.00 |
DisclosureSEC source: 0001345281-23-000004 · primary_doc.xml · nonDerivative · entry 1 Masi Dina · CIK 0001345281 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,200 F1 · kind: 50,000 common stock shares acquired upon exercise of stock option grant dated June 2, 2015. Read SEC document |
| July 18, 2023 Filed Jul 19, 2023 19:34 UTC |
Friedman Eric JDirector
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001345281-23-000002 · primary_doc.xml · derivative · entry 1 FRIEDMAN ERIC J · CIK 0001216280 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2033-07-18 F1 · derivative.exercise_price: The exercise price of each stock option will be the closing price of the Issuer's Common Stock on July 25, 2023, which represents the fifth trading day after the grant date. F2 · derivative.exercise_date: The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024. Read SEC document |
| July 18, 2023 Filed Jul 19, 2023 19:27 UTC |
DeSantis DamonDirector
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001345281-23-000001 · primary_doc.xml · derivative · entry 1 DeSantis Damon · CIK 0001889279 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2033-07-18 F1 · derivative.exercise_price: The exercise price of each stock option will be the closing price of the Issuer's Common Stock on July 25, 2023, which represents the fifth trading day after the grant date. F2 · derivative.exercise_date: The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024. Read SEC document |
| July 18, 2023 Filed Jul 19, 2023 19:06 UTC |
Canarick RobertDirector
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001382218-23-000001 · primary_doc.xml · derivative · entry 1 Canarick Robert · CIK 0001382218 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2033-07-18 F1 · derivative.exercise_price: The exercise price of each stock option will be the closing price of the Issuer's Common Stock on July 25, 2023, which represents the fifth trading day after the grant date. F2 · derivative.exercise_date: The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024. Read SEC document |
| July 18, 2023 Filed Jul 20, 2023 19:05 UTC |
Milmoe William H.Director · 10% owner
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001345281-23-000003 · primary_doc.xml · derivative · entry 1 Milmoe William H. · CIK 0001443194 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2033-07-18 F1 · derivative.exercise_price: The exercise price of each stock option will be the closing price of the Issuer's Common Stock on July 25, 2023, which represents the fifth trading day after the grant date. F2 · derivative.exercise_date: The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024. Read SEC document |
| May 30, 2023 Filed Jun 1, 2023 18:39 UTC |
RIVA SHEPPARDDirector · Co-Chief Executive Officer
|
GiftCommon Stock | 50,000 | $0.34 | $17,000.00 |
DisclosureSEC source: 0001064900-23-000001 · primary_doc.xml · nonDerivative · entry 1 RIVA SHEPPARD · CIK 0001064900 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,811,800 F1 · shares: Represents 50,000 common stock shares acquired upon gift from Heidi Kay, successor owner to Edward Gerald Kay of such shares upon transfer of ownership upon death. F2 · price: Closing price of Common Stock on date of gift, May 30, 2023. Read SEC document |
| May 30, 2023 Filed Jun 1, 2023 18:38 UTC |
KAY CHRISTINADirector · Co-Chief Executive Officer
|
GiftCommon Stock | 50,000 | $0.34 | $17,000.00 |
DisclosureSEC source: 0001064901-23-000001 · primary_doc.xml · nonDerivative · entry 1 KAY CHRISTINA · CIK 0001064901 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,811,800 F1 · shares: Represents 50,000 common stock shares acquired upon gift from Heidi Kay, successor owner to Edward Gerald Kay of such shares upon transfer of ownership upon death. F2 · price: Closing price of Common Stock on date of gift, May 30, 2023. Read SEC document |
| May 25, 2023 Filed Sep 21, 2023 20:17 UTC |
RIVA SHEPPARDDirector · Co-Chief Executive Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 21,667 | $0.00 Strike: $1.05 | $0.00 |
DisclosureSEC source: 0001064900-23-000002 · primary_doc.xml · derivative · entry 5 RIVA SHEPPARD · CIK 0001064900 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · As Co-Executor of the Estate of E Gerald Kay Disclosed balance after: 21,667 Underlying: Common Stock · 21,667 shares Expires 2024-03-20 F1 · date: Date Mrs. Sheppard was appointed Co-Executor of the Estate of E Gerald Kay. F1 · deemedExecutionDate: Date Mrs. Sheppard was appointed Co-Executor of the Estate of E Gerald Kay. Read SEC document |
| May 25, 2023 Filed Sep 21, 2023 20:17 UTC |
RIVA SHEPPARDDirector · Co-Chief Executive Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 66,667 | $0.00 Strike: $0.72 | $0.00 |
DisclosureSEC source: 0001064900-23-000002 · primary_doc.xml · derivative · entry 4 RIVA SHEPPARD · CIK 0001064900 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · As Co-Executor of the Estate of E Gerald Kay Disclosed balance after: 66,667 Underlying: Common Stock · 66,667 shares Expires 2024-03-20 F1 · date: Date Mrs. Sheppard was appointed Co-Executor of the Estate of E Gerald Kay. F1 · deemedExecutionDate: Date Mrs. Sheppard was appointed Co-Executor of the Estate of E Gerald Kay. F6 · derivative.exercise_date: 33,334 vested on November 4, 2021, the one year anniversary of the grant date and 33,333 vested on November 4, 2022, the second year anniversary of the grant date. Read SEC document |
| May 25, 2023 Filed Sep 21, 2023 20:17 UTC |
RIVA SHEPPARDDirector · Co-Chief Executive Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $0.23 | $0.00 |
DisclosureSEC source: 0001064900-23-000002 · primary_doc.xml · derivative · entry 3 RIVA SHEPPARD · CIK 0001064900 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · As Co-Executor of the Estate of E Gerald Kay Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2024-03-20 F1 · date: Date Mrs. Sheppard was appointed Co-Executor of the Estate of E Gerald Kay. F1 · deemedExecutionDate: Date Mrs. Sheppard was appointed Co-Executor of the Estate of E Gerald Kay. F5 · derivative.exercise_date: 25,000 vested on May 24, 2019 and 41,667 vested each May 24, 2020 and 2021 and 41,666 vested on May 24, 2022. Read SEC document |
| May 25, 2023 Filed Sep 21, 2023 20:17 UTC |
RIVA SHEPPARDDirector · Co-Chief Executive Officer · 10% owner
|
GrantCommon Stock | 3,410,512 | $0.40 | $1,364,204.80 |
DisclosureSEC source: 0001064900-23-000002 · primary_doc.xml · nonDerivative · entry 1 RIVA SHEPPARD · CIK 0001064900 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · As Co-Executor of the Estate of E Gerald Kay and as Trustee of the Emily Sheppard Trust Disclosed balance after: 3,426,212 F1 · date: Date Mrs. Sheppard was appointed Co-Executor of the Estate of E Gerald Kay. F1 · deemedExecutionDate: Date Mrs. Sheppard was appointed Co-Executor of the Estate of E Gerald Kay. F2 · price: Closing price of the Issuer's Common Stock on March 20, 2023, date of transfer into the Estate of E Gerald Kay. F3 · ownership.nature: 3,410,512 as Co-Executor of the Estate of E Gerald Kay and 15,700 as Trustee to the Emily Sheppard Trust. Read SEC document |
| May 25, 2023 Filed Sep 21, 2023 19:41 UTC |
KAY CHRISTINADirector · Co-Chief Executive Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 21,667 | $0.00 Strike: $1.05 | $0.00 |
DisclosureSEC source: 0001064901-23-000002 · primary_doc.xml · derivative · entry 5 KAY CHRISTINA · CIK 0001064901 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · As Co-Executor of the Estate of E Gerald Kay Disclosed balance after: 21,667 Underlying: Common Stock · 21,667 shares Expires 2024-03-20 F1 · date: Date Ms. Kay was appointed Co-Executor of the Estate of E Gerald Kay. F1 · deemedExecutionDate: Date Ms. Kay was appointed Co-Executor of the Estate of E Gerald Kay. Read SEC document |
| May 25, 2023 Filed Sep 21, 2023 19:41 UTC |
KAY CHRISTINADirector · Co-Chief Executive Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 66,667 | $0.00 Strike: $0.72 | $0.00 |
DisclosureSEC source: 0001064901-23-000002 · primary_doc.xml · derivative · entry 4 KAY CHRISTINA · CIK 0001064901 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · As Co-Executor of the Estate of E Gerald Kay Disclosed balance after: 66,667 Underlying: Common Stock · 66,667 shares Expires 2024-03-20 F1 · date: Date Ms. Kay was appointed Co-Executor of the Estate of E Gerald Kay. F1 · deemedExecutionDate: Date Ms. Kay was appointed Co-Executor of the Estate of E Gerald Kay. F5 · derivative.exercise_date: 33,334 vested on November 4, 2021, the one year anniversary of the grant date and 33,333 vested on November 4, 2022, the second year anniversary of the grant date. Read SEC document |
| May 25, 2023 Filed Sep 21, 2023 19:41 UTC |
KAY CHRISTINADirector · Co-Chief Executive Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $0.23 | $0.00 |
DisclosureSEC source: 0001064901-23-000002 · primary_doc.xml · derivative · entry 3 KAY CHRISTINA · CIK 0001064901 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · As Co-Executor of the Estate of E Gerald Kay Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2024-03-20 F1 · date: Date Ms. Kay was appointed Co-Executor of the Estate of E Gerald Kay. F1 · deemedExecutionDate: Date Ms. Kay was appointed Co-Executor of the Estate of E Gerald Kay. F4 · derivative.exercise_date: 25,000 vested on May 24, 2019 and in 41,667 vested each May 24, 2020 and 2021 and 41,666 vested on May 24, 2022. Read SEC document |
| May 25, 2023 Filed Sep 21, 2023 19:41 UTC |
KAY CHRISTINADirector · Co-Chief Executive Officer · 10% owner
|
GrantCommon Stock | 3,410,512 | $0.40 | $1,364,204.80 |
DisclosureSEC source: 0001064901-23-000002 · primary_doc.xml · nonDerivative · entry 1 KAY CHRISTINA · CIK 0001064901 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · As Co-Executor of the Estate of E Gerald Kay Disclosed balance after: 3,410,512 F1 · date: Date Ms. Kay was appointed Co-Executor of the Estate of E Gerald Kay. F2 · price: Closing price of the Issuer's Common Stock on March 20, 2023, date of transfer into the Estate of E Gerald Kay. Read SEC document |
| March 20, 2023 Filed Nov 16, 2023 21:13 UTC |
KAY E GERALDDirector · Executive Chairman & President · 10% owner
|
OtherStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $0.45 | $0.00 |
DisclosureSEC source: 0001345281-23-000006 · primary_doc.xml · derivative · entry 6 KAY E GERALD · CIK 0001053310 · Director · Executive Chairman & President · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2023-03-20 F6 · shares: None of the Options were vested at the time of passing of the Reporting Person. F2 · derivative.exercise_date: The option vested over three years beginning of the first year anniversary noted herein. F6 · derivative.expiration_date: None of the Options were vested at the time of passing of the Reporting Person. F6 · derivative.underlying_shares: None of the Options were vested at the time of passing of the Reporting Person. Read SEC document |
| March 20, 2023 Filed Nov 16, 2023 21:13 UTC |
KAY E GERALDDirector · Executive Chairman & President · 10% owner
|
OtherStock Option (right to buy) · Derivative | 65,000 | $0.00 Strike: $1.05 | $0.00 |
DisclosureSEC source: 0001345281-23-000006 · primary_doc.xml · derivative · entry 5 KAY E GERALD · CIK 0001053310 · Director · Executive Chairman & President · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 65,000 shares Expires 2024-03-20 F5 · shares: Includes 43,333 shares that were not vested at the time of the Reporting Person's passing. F2 · derivative.exercise_date: The option vested over three years beginning of the first year anniversary noted herein. F3 · derivative.expiration_date: Due to the passing of the Reporting Person, the Expiration Date is one year from the date of death. F5 · derivative.underlying_shares: Includes 43,333 shares that were not vested at the time of the Reporting Person's passing. Read SEC document |
| March 20, 2023 Filed Nov 16, 2023 21:13 UTC |
KAY E GERALDDirector · Executive Chairman & President · 10% owner
|
OtherStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $0.72 | $0.00 |
DisclosureSEC source: 0001345281-23-000006 · primary_doc.xml · derivative · entry 4 KAY E GERALD · CIK 0001053310 · Director · Executive Chairman & President · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2024-03-20 F4 · shares: Includes 33,333 shares that were not vested at the time of the Reporting Person's passing. F2 · derivative.exercise_date: The option vested over three years beginning of the first year anniversary noted herein. F3 · derivative.expiration_date: Due to the passing of the Reporting Person, the Expiration Date is one year from the date of death. F4 · derivative.underlying_shares: Includes 33,333 shares that were not vested at the time of the Reporting Person's passing. Read SEC document |
| March 20, 2023 Filed Nov 16, 2023 21:13 UTC |
KAY E GERALDDirector · Executive Chairman & President · 10% owner
|
OtherStock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $0.23 | $0.00 |
DisclosureSEC source: 0001345281-23-000006 · primary_doc.xml · derivative · entry 3 KAY E GERALD · CIK 0001053310 · Director · Executive Chairman & President · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 150,000 shares Expires 2024-03-20 F2 · derivative.exercise_date: The option vested over three years beginning of the first year anniversary noted herein. F3 · derivative.expiration_date: Due to the passing of the Reporting Person, the Expiration Date is one year from the date of death. Read SEC document |
| March 20, 2023 Filed Nov 16, 2023 21:13 UTC |
KAY E GERALDDirector · Executive Chairman & President · 10% owner
|
OtherCommon Stock | 853,022 | $0.00 | $0.00 |
DisclosureSEC source: 0001345281-23-000006 · primary_doc.xml · nonDerivative · entry 2 KAY E GERALD · CIK 0001053310 · Director · Executive Chairman & President · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · As sole member of LLC or Trustee of Trusts Disclosed balance after: 0 F1 · shares: Includes (i) 819,628 shares registered to the name of EGK LLC, an entity the Reporting Person was the sole member of and (ii) 16,697 shares held in each of the Riva Grantor Trust and Christina Kay Grantor Trust whereas the Reporting Person was the Trustee. F1 · ownership.nature: Includes (i) 819,628 shares registered to the name of EGK LLC, an entity the Reporting Person was the sole member of and (ii) 16,697 shares held in each of the Riva Grantor Trust and Christina Kay Grantor Trust whereas the Reporting Person was the Trustee. Read SEC document |
| March 20, 2023 Filed Nov 16, 2023 21:13 UTC |
KAY E GERALDDirector · Executive Chairman & President · 10% owner
|
OtherCommon Stock | 4,299,533 | $0.00 | $0.00 |
DisclosureSEC source: 0001345281-23-000006 · primary_doc.xml · nonDerivative · entry 1 KAY E GERALD · CIK 0001053310 · Director · Executive Chairman & President · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| November 09, 2022 Filed Nov 10, 2022 23:53 UTC |
KAY CHRISTINADirector · Co-Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001064901-22-000001 · primary_doc.xml · derivative · entry 1 KAY CHRISTINA · CIK 0001064901 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-11-09 F1 · derivative.exercise_price: The Exercise Price of the Stock Option will be the closing prices of the Issuer's Common Stock on the fifth trading day after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2022, with the Securities and Exchange Commission. F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 9, 2023. Read SEC document |
| November 09, 2022 Filed Nov 10, 2022 23:47 UTC |
RIVA SHEPPARDDirector · Co-Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001064900-22-000001 · primary_doc.xml · derivative · entry 1 RIVA SHEPPARD · CIK 0001064900 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-11-09 F1 · derivative.exercise_price: The Exercise Price of the Stock Option will be the closing prices of the Issuer's Common Stock on the fifth trading day after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2022, with the Securities and Exchange Commission. F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 9, 2023. Read SEC document |
| November 09, 2022 Filed Nov 10, 2022 23:39 UTC |
KAY E GERALDDirector · Executive Chairman & President · 10% owner
|
GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001053310-22-000003 · primary_doc.xml · derivative · entry 1 KAY E GERALD · CIK 0001053310 · Director · Executive Chairman & President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2027-11-09 F1 · derivative.exercise_price: The Exercise Price of the Stock Option will be 110% the closing prices of the Issuer's Common Stock on the fifth trading day after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2022, with the Securities and Exchange Commission. F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 9, 2023. Read SEC document |
| November 09, 2022 Filed Nov 10, 2022 23:27 UTC |
Masi DinaChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001345281-22-000003 · primary_doc.xml · derivative · entry 1 Masi Dina · CIK 0001345281 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-11-09 F1 · derivative.exercise_price: The Exercise Price of the Stock Option will be the closing prices of the Issuer's Common Stock on the fifth trading day after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2022, with the Securities and Exchange Commission. F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 9, 2023. Read SEC document |
| June 20, 2022 Filed Jun 21, 2022 21:33 UTC |
DeSantis DamonDirector
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001345281-22-000002 · primary_doc.xml · derivative · entry 1 DeSantis Damon · CIK 0001889279 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2032-06-20 F1 · derivative.exercise_price: The exercise price of each stock option will be the closing price of the Issuer's Common Stock on June 27, 2022, which represents the fifth trading day after the grant date. F2 · derivative.exercise_date: The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2022, December 31, 2022, March 31, 2023 and June 30, 2023. Read SEC document |
| June 20, 2022 Filed Jun 21, 2022 20:37 UTC |
Friedman Eric JDirector
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001216280-22-000001 · primary_doc.xml · derivative · entry 1 FRIEDMAN ERIC J · CIK 0001216280 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2032-06-20 F1 · derivative.exercise_price: The exercise price of each stock option will be the closing price of the Issuer's Common Stock on June 27, 2022, which represents the fifth trading day after the grant date. F2 · derivative.exercise_date: The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2022, December 31, 2022, March 31, 2023 and June 30, 2023. Read SEC document |
| June 20, 2022 Filed Jun 21, 2022 20:29 UTC |
Milmoe William H.Director · 10% owner
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001443194-22-000001 · primary_doc.xml · derivative · entry 1 Milmoe William H. · CIK 0001443194 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2032-06-20 F1 · derivative.exercise_price: The exercise price of each stock option will be the closing price of the Issuer's Common Stock on June 27, 2022, which represents the fifth trading day after the grant date. F2 · derivative.exercise_date: The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2022, December 31, 2022, March 31, 2023 and June 30, 2023. Read SEC document |
| June 20, 2022 Filed Jun 21, 2022 20:19 UTC |
Canarick RobertDirector
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001382218-22-000001 · primary_doc.xml · derivative · entry 1 Canarick Robert · CIK 0001382218 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2032-06-20 F1 · derivative.exercise_price: The exercise price of each stock option will be the closing price of the Issuer's Common Stock on June 27, 2022, which represents the fifth trading day after the grant date. F2 · derivative.exercise_date: The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2022, December 31, 2022, March 31, 2023 and June 30, 2023. Read SEC document |
| May 06, 2022 Filed May 6, 2022 21:08 UTC |
KAY E GERALDDirector · Executive Chairman & President · 10% owner
|
GrantCommon Stock | 100,000 | $0.23 | $23,000.00 |
DisclosureSEC source: 0001053310-22-000001 · primary_doc.xml · nonDerivative · entry 1 KAY E GERALD · CIK 0001053310 · Director · Executive Chairman & President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,345,889 F1 · kind: 100,000 common stock shares acquired upon exercise of stock option grant dated May 24, 2019. Read SEC document |
| May 06, 2022 Filed May 11, 2022 18:37 UTC Amendment |
KAY E GERALDDirector · Executive Chairman & President · 10% owner
|
Exercise / conversionStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $0.23 | $0.00 |
DisclosureSEC source: 0001053310-22-000002 · primary_doc.xml · derivative · entry 2 KAY E GERALD · CIK 0001053310 · Director · Executive Chairman & President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 100,000 shares Expires 2024-05-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested 50% (125,000) on grant date (May 24, 2019) and in three equal annual installments for the remaining 50% (125,000) beginning on May 24, 2020 and ending May 24, 2022. Read SEC document |
| May 06, 2022 Filed May 11, 2022 18:37 UTC Amendment |
KAY E GERALDDirector · Executive Chairman & President · 10% owner
|
Exercise / conversionCommon Stock | 100,000 | $0.23 | $23,000.00 |
DisclosureSEC source: 0001053310-22-000002 · primary_doc.xml · nonDerivative · entry 1 KAY E GERALD · CIK 0001053310 · Director · Executive Chairman & President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,345,889 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This Form 4 is being amended to correct the Transaction Code in Table 1 and to include the previously inadvertently omitted disclosure in Table II. F2 · security: 100,000 common stock shares acquired upon exercise of stock option grant dated May 24, 2019. Read SEC document |
| November 03, 2021 Filed Nov 3, 2021 22:51 UTC |
Friedman Eric JDirector
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001345281-21-000003 · primary_doc.xml · derivative · entry 1 FRIEDMAN ERIC J · CIK 0001216280 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-11-03 F1 · derivative.exercise_price: The Exercise Price of the Stock Option will be the closing prices of the Issuer's Common Stock five trading days after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2021, with the Securities and Exchange Commission(the "Issue Date"). F2 · derivative.exercise_date: The option vests and becomes exercisable as follows: 25% (12,500 shares) on the Issue Date, 25% (12,500 shares) on December 31, 2021, 25% (12,500 shares) on March 31, 2022 and 25% (12,500 shares) on June 30, 2022. Read SEC document |
| November 03, 2021 Filed Nov 3, 2021 22:46 UTC |
Canarick RobertDirector
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001345281-21-000002 · primary_doc.xml · derivative · entry 1 Canarick Robert · CIK 0001382218 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-11-03 F1 · derivative.exercise_price: The Exercise Price of the Stock Option will be the closing prices of the Issuer's Common Stock five trading days after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2021, with the Securities and Exchange Commission (the "Issue Date"). F2 · derivative.exercise_date: The option vests and becomes exercisable as follows: 25% (12,500 shares) on the Issue Date, 25% (12,500 shares) on December 31, 2021, 25% (12,500 shares) on March 31, 2022 and 25% (12,500 shares) on June 30, 2022. Read SEC document |
| November 03, 2021 Filed Nov 3, 2021 22:33 UTC |
Masi DinaChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 65,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001345281-21-000001 · primary_doc.xml · derivative · entry 1 Masi Dina · CIK 0001345281 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2031-11-03 F1 · derivative.exercise_price: The Exercise Price of the Stock Option will be the closing prices of the Issuer's Common Stock five trading days after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2021, with the Securities and Exchange Commission. F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 3, 2022. Read SEC document |
| November 03, 2021 Filed Nov 3, 2021 22:07 UTC |
RIVA SHEPPARDDirector · Co-Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 65,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001064900-21-000001 · primary_doc.xml · derivative · entry 1 RIVA SHEPPARD · CIK 0001064900 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2031-11-03 F1 · derivative.exercise_price: The Exercise Price of the Stock Option will be the closing price of the Issuer's Commons Stock five trading days after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2021, with the Securities and Exchange Commission. F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 3, 2022. Read SEC document |
| November 03, 2021 Filed Nov 3, 2021 22:25 UTC |
KAY CHRISTINADirector · Co-Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 65,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001064901-21-000001 · primary_doc.xml · derivative · entry 1 KAY CHRISTINA · CIK 0001064901 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2031-11-03 F1 · derivative.exercise_price: The Exercise Price of the Stock Option will be the closing prices of the Issuer's Common Stock five trading days after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2021, with the Securities and Exchange Commission. F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 3, 2022. Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 16:16 UTC |
DESANTIS CARLDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001102948-21-000001 · primary_doc.xml · derivative · entry 1 DESANTIS CARL · CIK 0001102948 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-11-03 F1 · derivative.exercise_price: The Exercise Price of the Stock Option will be 110% of the closing price of the Issuer's Common Stock five trading days after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2021, with the Securities and Exchange Commission(the "Issue Date"). F2 · derivative.exercise_date: The option vests and becomes exercisable as follows: 25% (12,500 shares) on the Issue Date, 25% (12,500 shares) on December 31, 2021, 25% (12,500 shares) on March 31, 2022 and 25% (12,500 shares) on June 30, 2022. Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 16:22 UTC |
Milmoe William H.Director · 10% owner
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001443194-21-000001 · primary_doc.xml · derivative · entry 1 Milmoe William H. · CIK 0001443194 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-11-03 F1 · derivative.exercise_price: The Exercise Price of the Stock Option will be the closing price of the Issuer's Common Stock five trading days after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2021, with the Securities and Exchange Commission(the "Issue Date"). F2 · derivative.exercise_date: The option vests and becomes exercisable as follows: 25% (12,500 shares) on the Issue Date, 25% (12,500 shares) on December 31, 2021, 25% (12,500 shares) on March 31, 2022 and 25% (12,500 shares) on June 30, 2022. Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 14:52 UTC |
KAY E GERALDDirector · Executive Chairman & President · 10% owner
|
GrantStock Option (right to buy) · Derivative | 65,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001053310-21-000001 · primary_doc.xml · derivative · entry 1 KAY E GERALD · CIK 0001053310 · Director · Executive Chairman & President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2026-11-03 F1 · derivative.exercise_price: The Exercise Price of the Stock Option will be 110% of the closing price of the Issuer's Common Stock five trading days after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2021, with the Securities and Exchange Commission. F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 3, 2022. Read SEC document |
| November 04, 2020 Filed Nov 20, 2020 22:18 UTC |
DESANTIS CARLDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.72 | $0.00 |
DisclosureSEC source: 0001345281-20-000008 · primary_doc.xml · derivative · entry 1 DESANTIS CARL · CIK 0001102948 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-11-04 F1 · derivative.exercise_date: The option vests and becomes exercisable as follows: 42% (20,831 shares) on November 19, 2020 and in seven equal monthly installments for the remaining 58% (29,169 shares) beginning on December 1, 2020. Read SEC document |
| November 04, 2020 Filed Nov 20, 2020 22:13 UTC |
KAY E GERALDDirector · Executive Chairman & President · 10% owner
|
GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $0.72 | $0.00 |
DisclosureSEC source: 0001345281-20-000007 · primary_doc.xml · derivative · entry 1 KAY E GERALD · CIK 0001053310 · Director · Executive Chairman & President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2025-11-04 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on November 4, 2021. Read SEC document |
| November 04, 2020 Filed Nov 20, 2020 22:07 UTC |
Canarick RobertDirector
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.65 | $0.00 |
DisclosureSEC source: 0001345281-20-000006 · primary_doc.xml · derivative · entry 1 Canarick Robert · CIK 0001382218 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-11-04 F1 · derivative.exercise_date: The option vests and becomes exercisable as follows: 42% (20,831 shares) on November 19, 2020 and in seven equal monthly installments for the remaining 58% (29,169 shares) beginning on December 1, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.